Maloney says the reduction in the placebo group is a reflection of thetypical placebo response.
马洛尼说，安慰剂组的周长减少是典型的安慰剂反应的反映。
After eight months, the diazoxide group outperformed the placebo group on both learning and memory.
八个月之后，氯甲苯噻嗪组小鼠在学习和记忆能力方面都优于安慰剂组。
Treatment duration was a median of 23 weeks in the sorafenib group and 19 weeks in the placebo group.
治疗时间中位数在索拉非尼组为23周，在安慰剂组为19周。
Off-treatment, at all sites, there was a decline in women in both the treatment group and the placebo group.
停止治疗以后，在所有检测点，无论治疗组还是安慰剂对照组骨密度均有下降。
The study didn't have a placebo group for comparison, generally considered necessary for a conclusive result.
研究没有设置服用安慰剂的对照组，通常要得出决定性的结论，对照组是必不可少的。
There were no significant changes in these markers in the placebo group over the entire 48 months of the study.
在研究的48个月期间，安慰剂组这些标志物没有明显改变。
Only 1 new fingertip ulcer was reported in the tadalafil group, compared with 13 new ulcers in the placebo group.
在他达拉非组治疗期间仅产生一片新的溃疡，而安慰剂组则是13片。
T he amount of liver inflammation was also significantly reduced in the treatment group but not the placebo group.
肝脏炎症总量在治疗组也得到明显改善，安慰剂组无变化。
Results 219 patients completed the study according to the protocol, 114 in Metadoxine group and 105 in placebo group.
结果219例患者按方案完成研究，其中试验组114例，安慰剂组105例。
In pancreatic cancer trials, the incidence of these events was 2.5% in the Tarceva group and 0.4% in the placebo group.
胰腺癌试验中，特罗凯组中发生这些事件的比率为2.5%，安慰剂组中此比率为0.4%。
Insulin sensitivity in the liver improved by 48 percent in the pioglitazone group, compared to 14 percent in the placebo group.
与安慰剂组的14%相比，服用吡格列酮组肝脏的胰岛素敏感型改善了48%。
More women who took hormones died from breast cancer - 0.03 percent per year, versus 0.01 percent per year in the placebo group.
服用激素且死于乳腺癌的妇女比对照组多，每年的死亡率分别为0.03%和0.01%。
Those who took it had about 50% fewer heart attacks and strokes, and their overall death rate was 20% lower than in the placebo group.
服用该药的心脏病发作及卒中的发生率降低了50%。全因死亡率较安慰剂组降低了20%。
More patients in the rituximab group than in the placebo group had adverse events, mostly grade 1 or grade 2, after the first infusion.
更多的利妥昔单抗组的患者在第一次注射后发生不良反应，大多数都是1或2级的。
It's worth noting that the varenicline takers also smoked far fewer cigarettes than the placebo group during the 14-hour the experiment.
值得注意的是在这14个小时的实验时间里varenicline服用者抽烟的次数也远少于placebo服用者。
In contrast to the placebo group a progressive increase of total and free TFPI was determined after the administration of the MPS cream.
与安慰剂组不同的是，多磺酸粘多糖乳膏组，总的和游离的组织因子旁路抑制因子水平持续增加。
Women in the placebo group, not on an aromatase inhibitor, maintained BMD at the spine, but had a significant 1.2% loss at the total hip.
未服用芳香化酶抑制剂的妇女脊柱骨密度保持不变，全髋关节下降1.2%。
Twelve months after the procedure, the transplant subjects were able to double their improvement on a treadmill compared to the placebo group.
手术后的12个月，移植实验者相比安慰剂组在跑步机上能有两倍的改善。
BMD at 48 months was strongly correlated with baseline, but women who had received denosumab maintained higher BMD than the placebo group.
在第48个月，骨密度与基线高度相关，但经过狄诺塞麦治疗的妇女骨密度一直高于安慰剂组。
That translates to 2.6 deaths per 10, 000 women per year among those taking hormones, twice the 1.3 deaths per 10, 000 in the placebo group.
也就是说，10000名服用激素的妇女中有2.6人死亡，而对照组有1.3人死亡，服用激素组是对照组的两倍。
In addition, they had very favorable outcome rates in the placebo group, thereby making it hard to demonstrate a benefit by their sample sizes.
此外，两项研究中的安慰剂组有非常好的结局，使得根据它们目前的样本量很难得出孕激素有益的结论。
The most common adverse events reported for the full-dose, mid-dose and placebo group were tingling, dry mouth, altered taste and constipation.
最常见的不良反应事件的报告充分剂量，中剂量和安慰剂组分别为刺痛，口干，改变口味和便秘。
Subjects in one of four calcium subgroups noted a 54 per cent reduction in aches and pains, while the placebo group had a 15 per cent increase.
四个钙服用分组之一的受试者中有54%的人觉得疼痛减弱，而安慰剂服用组则有15%的人觉得疼痛加剧。 收藏。
Although myalgia and pyrexia were more common in treatment groups, dropout rates related to treatment were similar to those in the placebo group.
尽管治疗组中，肌痛与发热更为常见，但由于治疗反应而推出的比例，与安慰剂组类似。
After six weeks, participants in the research took another series of tests and no difference was found between the ginkgo group and the placebo group.
但是六周后，参与研究的人再度进行一系列的试验，却发现服用银杏与服用安慰剂的两组人之间并没有差异。
Subjects in the placebo group did not realize any benefits on PET regional myocardial blood flow, coronary flu, exercise tolerance or hemodynamic variables.
而安慰剂组的各项指标无任何改善，包括PET区域心肌血流量，冠脉血流量，运动耐量或者血流动力学变量。
RESULTS: Actovegin group showed much higher rates of improvement in cognitive function and clinical global impression than those of placebo group (P< 0.01).
结果：爱维治组在认知功能、临床总体疗效方面改善率均显著高于安慰剂组（P＜0．01），爱维治组日常生活功能也较治疗前有明显提高（P＜0．01）。
RESULTS: Actovegin group showed much higher rates of improvement in cognitive function and clinical global impression than those of placebo group (P< 0.01).
结果：爱维治组在认知功能、临床总体疗效方面改善率均显著高于安慰剂组（P＜0．01），爱维治组日常生活功能也较治疗前有明显提高（P＜0．01）。
应用推荐